Literature DB >> 16119181

Validity of an abbreviated quality of life enjoyment and satisfaction questionnaire (Q-LES-Q-18) for schizophrenia, schizoaffective, and mood disorder patients.

Michael Ritsner1, Rena Kurs, Anatoly Gibel, Yael Ratner, Jean Endicott.   

Abstract

We sought to identify a core subset of Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q) items that maintains the validity and psychometric properties of the basic version. A parsimonious subset of items from the Q-LES-Q that can accurately predict the basic Q-LES-Q domain mean scores was sought and evaluated in 339 inpatients meeting DSM-IV criteria for schizophrenia, schizoaffective, and mood disorders. Three additional data sets were used for validation. Assessments included Q-LES-Q, Quality of Life Scale, Lancashire Quality of Life Profile, rating scales for psychopathology, medication side effects, and self-reported emotional distress, self-esteem, self-efficacy, and social support. We found that 18-items predicted basic Q-LES-Q domains (physical health, subjective feelings, leisure time activities, social relationships) and general index scores with high accuracy. Q-LES-Q-18 showed high reliability, validity, and stability of test-retest ratings. Thus, Q-LES-Q-18, a brief, self-administered questionnaire may aid in monitoring quality of life outcomes of schizophrenia, schizoaffective, and mood disorder patients.

Entities:  

Mesh:

Year:  2005        PMID: 16119181     DOI: 10.1007/s11136-005-2816-9

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  46 in total

1.  Refining quality of life: validating a multidimensional factor measure in the severe mentally ill.

Authors:  S L Bishop; D P Walling; S G Dott; C C Folkes; J Bucy
Journal:  Qual Life Res       Date:  1999       Impact factor: 4.147

2.  Determinants of subjective quality of life in patients attending community-based mental health services. The South-Verona Outcome Project 5.

Authors:  M Ruggeri; R Gater; G Bisoffi; C Barbui; M Tansella
Journal:  Acta Psychiatr Scand       Date:  2002-02       Impact factor: 6.392

Review 3.  Measuring quality of life: methodological issues.

Authors:  M Dijkers
Journal:  Am J Phys Med Rehabil       Date:  1999 May-Jun       Impact factor: 2.159

4.  Testosterone replacement therapy for hypogonadal men with SSRI-refractory depression.

Authors:  S N Seidman; J G Rabkin
Journal:  J Affect Disord       Date:  1998-03       Impact factor: 4.839

5.  Subject and observer-rated quality of life in schizophrenia.

Authors:  P B Fitzgerald; C L Williams; N Corteling; S L Filia; K Brewer; A Adams; A R de Castella; T Rolfe; P Davey; J Kulkarni
Journal:  Acta Psychiatr Scand       Date:  2001-05       Impact factor: 6.392

6.  Divalproex sodium versus olanzapine in the treatment of acute mania in bipolar disorder: health-related quality of life and medical cost outcomes.

Authors:  Dennis A Revicki; L Clark Paramore; Kenneth W Sommerville; Alan C Swann; John M Zajecka
Journal:  J Clin Psychiatry       Date:  2003-03       Impact factor: 4.384

7.  Posttraumatic stress disorder and quality of life: results across 64 weeks of sertraline treatment.

Authors:  Mark H Rapaport; Jean Endicott; Cathryn M Clary
Journal:  J Clin Psychiatry       Date:  2002-01       Impact factor: 4.384

8.  Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure.

Authors:  J Endicott; J Nee; W Harrison; R Blumenthal
Journal:  Psychopharmacol Bull       Date:  1993

9.  Subjective quality of life: its relationship with clinician-rated and patient-rated psychopathology. The South-Verona Outcome Project 6.

Authors:  Antonio Lasalvia; Mirella Ruggeri; Nazario Santolini
Journal:  Psychother Psychosom       Date:  2002 Sep-Oct       Impact factor: 17.659

10.  Impact of antipsychotic agents and their side effects on the quality of life in schizophrenia.

Authors:  Michael Ritsner; Rena Kurs
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2002-08       Impact factor: 2.217

View more
  51 in total

1.  Comparative efficacy and durability of continuation phase cognitive therapy for preventing recurrent depression: design of a double-blinded, fluoxetine- and pill placebo-controlled, randomized trial with 2-year follow-up.

Authors:  Robin B Jarrett; Michael E Thase
Journal:  Contemp Clin Trials       Date:  2010-05-06       Impact factor: 2.226

2.  Pathological gambling and posttraumatic stress disorder: a study of the co-morbidity versus each alone.

Authors:  Lisa M Najavits; Tamar Meyer; Kay M Johnson; David Korn
Journal:  J Gambl Stud       Date:  2011-12

3.  Psychiatric symptoms and quality of life in schizophrenia: a meta-analysis.

Authors:  Shaun M Eack; Christina E Newhill
Journal:  Schizophr Bull       Date:  2007-01-04       Impact factor: 9.306

4.  High rates of obstructive sleep apnea symptoms among patients with schizophrenia.

Authors:  Aniyizhai Annamalai; Laura B Palmese; Lydia A Chwastiak; Vinod H Srihari; Cenk Tek
Journal:  Psychosomatics       Date:  2014-03-02       Impact factor: 2.386

5.  Quality of life across domains among individuals with treatment-resistant depression.

Authors:  Heidemarie Lex; Yarden Ginsburg; Adam F Sitzmann; Clara Grayhack; Daniel F Maixner; Brian J Mickey
Journal:  J Affect Disord       Date:  2018-09-19       Impact factor: 4.839

6.  Personality traits predicting quality of life and overall functioning in schizophrenia.

Authors:  Caitlin Ridgewell; Jennifer Urbano Blackford; Maureen McHugo; Stephan Heckers
Journal:  Schizophr Res       Date:  2016-10-13       Impact factor: 4.939

7.  Leisure as a context for active living, recovery, health and life quality for persons with mental illness in a global context.

Authors:  Yoshitaka Iwasaki; Catherine P Coyle; John W Shank
Journal:  Health Promot Int       Date:  2010-06-12       Impact factor: 2.483

8.  Implications of weight-based stigma and self-bias on quality of life among individuals with schizophrenia.

Authors:  Jessica A Barber; Laura Palmese; Erin L Reutenauer; Carlos M Grilo; Cenk Tek
Journal:  J Nerv Ment Dis       Date:  2011-07       Impact factor: 2.254

9.  Insomnia is frequent in schizophrenia and associated with night eating and obesity.

Authors:  Laura B Palmese; Pamela C DeGeorge; Joseph C Ratliff; Vinod H Srihari; Bruce E Wexler; Andrew D Krystal; Cenk Tek
Journal:  Schizophr Res       Date:  2011-12       Impact factor: 4.939

10.  Effectiveness and weight effects of open-label lamotrigine with and without concomitant psychotropic medications in patients with bipolar I disorder.

Authors:  Michael N Zarzar; Jay Graham; Jeremy Roberts; Thomas Thompson; Kevin Nanry
Journal:  MedGenMed       Date:  2007-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.